Where USH2A function is severely impaired, [for instance, with biallelic loss of function (LOF) variants], moderate-to-severe early-onset hearing impairment is also present, leading to USH2 (first described by Albrecht von Gräfe in 1858) [1,2,3,4]. The gene discussed is USH2A; the disease is hearing loss disorder.